{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:03:46Z","timestamp":1790071426643,"version":"4.0.1"},"publisher-location":"New York, NY","reference-count":61,"publisher":"Springer US","isbn-type":[{"value":"9781071655467","type":"print"},{"value":"9781071655474","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2027]]},"DOI":"10.1007\/978-1-0716-5547-4_5","type":"book-chapter","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:19:09Z","timestamp":1790068749000},"page":"75-92","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An Overview of Programmable Epigenetic Editing Based on CRISPR Tools for Gene Expression Regulation"],"prefix":"10.1007","author":[{"given":"Marija","family":"Djordjevi\u010d","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Dini\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Sari\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Uskokovi\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melita","family":"Vidakovi\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrg.2016.59","volume":"17","author":"CD Allis","year":"2016","unstructured":"Allis CD, Jenuwein T (2016) The molecular hallmarks of epigenetic control. Nat Rev Genet 17:487\u2013500","journal-title":"Nat Rev Genet"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41580-019-0159-6","volume":"20","author":"MVC Greenberg","year":"2019","unstructured":"Greenberg MVC, Bourc\u2019his D (2019) The diverse roles of DNA methylation in mammalian development and disease. Nat Rev Mol Cell Biol 20:590\u2013607","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister AJ, Kouzarides T (2011) Regulation of chromatin by histone modifications. Cell Res 21:381\u2013395","journal-title":"Cell Res"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS et al. (2023) Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol 24:430\u2013447","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nrm.2017.26","volume":"18","author":"CR Clapier","year":"2017","unstructured":"Clapier CR, Iwasa J, Cairns BR, Peterson CL (2017) Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes. Nat Rev Mol Cell Biol 18:407\u2013422","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.3390\/ijms26104929","volume":"26","author":"DB Olawade","year":"2025","unstructured":"Olawade DB et al. (2025) Reversing epigenetic dysregulation in neurodegenerative diseases: mechanistic and therapeutic considerations. Int J Mol Sci 26:4929","journal-title":"Int J Mol Sci"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"eaaw3835","DOI":"10.1126\/science.aaw3835","volume":"379","author":"AP Feinberg","year":"2023","unstructured":"Feinberg AP, Levchenko A (2023) Epigenetics as a mediator of plasticity in cancer. Science 379:eaaw3835","journal-title":"Science"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41392-023-01333-7","volume":"8","author":"YL Wu","year":"2023","unstructured":"Wu YL et al. (2023) Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. Sig Transduct Target Ther 8:98","journal-title":"Sig Transduct Target Ther"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nbt.1678","volume":"28","author":"TK Kelly","year":"2010","unstructured":"Kelly TK, De Carvalho DD, Jones PA (2010) Epigenetic modifications as therapeutic targets. Nat Biotechnol 28:1069\u20131078","journal-title":"Nat Biotechnol"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41392-024-02039-0","volume":"9","author":"W Dai","year":"2024","unstructured":"Dai W et al. (2024) Epigenetics-targeted drugs: current paradigms and future challenges. Sig Transduct Target Ther 9:332","journal-title":"Sig Transduct Target Ther"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrg.2016.93","volume":"17","author":"P Jones","year":"2016","unstructured":"Jones P, Issa JP, Baylin S (2016) Targeting the cancer epigenome for therapy. Nat Rev Genet 17:630\u2013641","journal-title":"Nat Rev Genet"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1172\/JCI69738","volume":"124","author":"AC West","year":"2014","unstructured":"West AC, Johnstone RW (2014) New and emerging HDAC inhibitors for cancer treatment. J Clin Invest 124:30\u201339","journal-title":"J Clin Invest"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","volume":"152","author":"L Qi","year":"2013","unstructured":"Qi L, Larson M, Gilbert L et al. (2013) Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152:1173\u20131183","journal-title":"Cell"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"10596","DOI":"10.1093\/nar\/gks863","volume":"40","author":"ML de Groote","year":"2012","unstructured":"de Groote ML, Verschure PJ, Rots MG (2012) Epigenetic editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes. Nucleic Acids Res 40:10596\u201310613","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"5_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.11","volume":"49","author":"K Hyun","year":"2017","unstructured":"Hyun K, Jeon J, Park K, Kim J (2017) Writing, erasing and reading histone lysine methylations. Exp Mol Med 49(4):e324","journal-title":"Exp Mol Med"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/nsmb.2436","volume":"19","author":"C Musselman","year":"2012","unstructured":"Musselman C, Lalonde ME, C\u00f4t\u00e9 J et al. (2012) Perceiving the epigenetic landscape through histone readers. Nat Struct Mol Biol 19:1218\u20131227","journal-title":"Nat Struct Mol Biol"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1523\/JNEUROSCI.1604-18.2018","volume":"39","author":"GC Sartor","year":"2019","unstructured":"Sartor GC et al. (2019) Enhancement of BDNF expression and memory by HDAC inhibition requires BET bromodomain reader proteins. J. Neurosci. 39:612\u2013626","journal-title":"J. Neurosci."},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"590195","DOI":"10.3389\/fcell.2020.590195","volume":"8","author":"A DasGupta","year":"2020","unstructured":"DasGupta A, Lee TL, Li C, Saltzman AL (2020) Emerging roles for chromo domain proteins in genome organization and cell fate in C. elegans. Front Cell Dev Biol 8:590195","journal-title":"Front Cell Dev Biol"},{"key":"5_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04252-2","volume":"9","author":"M Adli","year":"2018","unstructured":"Adli M (2018) The CRISPR tool kit for genome editing and beyond. Nat Commun 9: 1911","journal-title":"Nat Commun"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.tig.2023.08.003","volume":"39","author":"DT Olga Rosspopoff","year":"2023","unstructured":"Olga Rosspopoff DT (2023) Take a walk on the KRAB side. Trends in Genetics 39:844\u2013857","journal-title":"Trends in Genetics"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.1093\/nar\/gkw159","volume":"44","author":"A Vojta","year":"2016","unstructured":"Vojta A et al. (2016) Repurposing the CRISPR-Cas9 system for targeted DNA methylation. Nucleic Acids Res 44:5615\u20135628","journal-title":"Nucleic Acids Res"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1093\/nar\/gkw1112","volume":"45","author":"P Stepper","year":"2017","unstructured":"Stepper P et al. (2017) Efficient targeted DNA methylation with chimeric dCas9-Dnmt3a-Dnmt3L methyltransferase. Nucleic Acids Res 45:1703","journal-title":"Nucleic Acids Res"},{"key":"5_CR23","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/j.cell.2021.03.025","volume":"184","author":"JK Nu\u00f1ez","year":"2021","unstructured":"Nu\u00f1ez JK et al. (2021) Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing. Cell 184:2503\u20132519","journal-title":"Cell"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"1134478","DOI":"10.3389\/fendo.2023.1134478","volume":"14","author":"M \u0110or\u0111evi\u0107","year":"2023","unstructured":"\u0110or\u0111evi\u0107 M et al. (2023) EpiCRISPR targeted methylation of Arx gene initiates transient switch of mouse pancreatic alpha to insulin-producing cells. Front. Endocrinol. 14:1134478","journal-title":"Front. Endocrinol."},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nmeth.3325","volume":"12","author":"NA Kearns","year":"2015","unstructured":"Kearns NA et al. (2015) Functional annotation of native enhancers with a Cas9-histone demethylase fusion. Nat Methods 12:401\u2013403","journal-title":"Nat Methods"},{"key":"5_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-54179-x","volume":"9","author":"S Sajwan","year":"2019","unstructured":"Sajwan S, Mannervik M (2019) Gene activation by dCas9-CBP and the SAM system differ in target preference. Sci Rep 9: 18104","journal-title":"Sci Rep"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nmeth.3871","volume":"13","author":"A Chavez","year":"2016","unstructured":"Chavez A et al. (2016) Comparison of Cas9 activators in multiple species. Nat Methods 13:563\u2013567","journal-title":"Nat Methods"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nature14136","volume":"517","author":"S Konermann","year":"2015","unstructured":"Konermann S et al. (2015) Genome-scale transcriptional activation by an engineered CRISPR\u2013Cas9 complex. Nature 517:583\u2013588","journal-title":"Nature"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2014.09.039","volume":"159","author":"ME Tanenbaum","year":"2014","unstructured":"Tanenbaum ME et al. (2014) A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell 159:635\u2013646","journal-title":"Cell"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/s41588-024-01706-w","volume":"56","author":"C Policarpi","year":"2024","unstructured":"Policarpi C et al. (2024) Systematic epigenome editing captures the context-dependent instructive function of chromatin modifications. Nat Genet 56:1168\u20131180","journal-title":"Nat Genet"},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/s41593-017-0060-6","volume":"21","author":"H Zhou","year":"2018","unstructured":"Zhou H et al. (2018) In vivo simultaneous transcriptional activation of multiple genes in the brain using CRISPR\u2013dCas9-activator transgenic mice. Nat Neurosci 21:440\u2013446","journal-title":"Nat Neurosci"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nbt.3658","volume":"34","author":"S Morita","year":"2016","unstructured":"Morita S et al. (2016) Targeted DNA demethylation in vivo using dCas9\u2013peptide repeat and scFv\u2013TET1 catalytic domain fusions. Nat Biotechnol 34:1060\u20131065","journal-title":"Nat Biotechnol"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nbt.3199","volume":"33","author":"IB Hilton","year":"2015","unstructured":"Hilton IB et al. (2015) Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol 33:510\u2013517","journal-title":"Nat Biotechnol"},{"key":"5_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63167-x","volume":"16","author":"D Xu","year":"2025","unstructured":"Xu D et al. (2025) Programmable epigenome editing by transient delivery of CRISPR epigenome editor ribonucleoproteins. Nat Commun 16: 7948","journal-title":"Nat Commun"},{"key":"5_CR35","doi-asserted-by":"crossref","unstructured":"Pan R et al. (2025) Editing DNA methylation in vivo. Nat Commun 17:527","DOI":"10.1038\/s41467-025-67222-5"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/brain\/awaa045","volume":"143","author":"G Colasante","year":"2020","unstructured":"Colasante G et al. (2020) In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy. Brain 143:891\u2013905","journal-title":"Brain"},{"key":"5_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50515-6","volume":"15","author":"B Kantor","year":"2024","unstructured":"Kantor B et al. (2024) The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders. Nat Commun 15: 7259","journal-title":"Nat Commun"},{"key":"5_CR38","doi-asserted-by":"crossref","unstructured":"Tremblay F et al (2025) A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels. Nat Med 31:1329\u20131338","DOI":"10.1038\/s41591-025-03508-x"},{"issue":"24","key":"5_CR39","first-page":"00309-X","volume":"S2451-9456","author":"GV Roth","year":"2024","unstructured":"Roth GV, Gengaro IR, Qi LS (2024) Precision epigenetic editing: technological advances, enduring challenges, and therapeutic applications. Cell Chem Biol S2451-9456(24):00309-X","journal-title":"Cell Chem Biol"},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"12453","DOI":"10.1093\/nar\/gkaa1000","volume":"48","author":"A Sgro","year":"2020","unstructured":"Sgro A, Blancafort P (2020) Epigenome engineering: new technologies for precision medicine. Nucleic Acids Res 48:12453\u201312482","journal-title":"Nucleic Acids Res"},{"key":"5_CR41","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/nar\/gkx1199","volume":"46","author":"DE Ryan","year":"2018","unstructured":"Ryan DE et al. (2018) Improving CRISPR-Cas specificity with chemical modifications in single-guide RNAs. Nucleic Acids Res 46:792\u2013803","journal-title":"Nucleic Acids Res"},{"key":"5_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41829-y","volume":"14","author":"L Zhao","year":"2023","unstructured":"Zhao L et al. (2023) PAM-flexible genome editing with an engineered chimeric Cas9. Nat Commun 14: 6175","journal-title":"Nat Commun"},{"key":"5_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1591-1","volume":"19","author":"N Amrani","year":"2018","unstructured":"Amrani N et al. (2018) NmeCas9 is an intrinsically high-fidelity genome-editing platform. Genome Biol 19: 214","journal-title":"Genome Biol"},{"key":"5_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14500","volume":"8","author":"E Kim","year":"2017","unstructured":"Kim E et al. (2017) In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni. Nat. Commun. 8: 14500","journal-title":"Nat. Commun."},{"key":"5_CR45","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/s41587-019-0235-7","volume":"37","author":"A Pickar-Oliver","year":"2019","unstructured":"Pickar-Oliver A et al. (2019) Targeted transcriptional modulation with type I CRISPR\u2013Cas systems in human cells. Nat Biotechnol 37:1493","journal-title":"Nat Biotechnol"},{"key":"5_CR46","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nchembio.1753","volume":"11","author":"LR Polstein","year":"2015","unstructured":"Polstein LR, Gersbach CA (2015) A light-inducible CRISPR-Cas9 system for control of endogenous gene activation. Nat Chem Biol 11:198\u2013200","journal-title":"Nat Chem Biol"},{"key":"5_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1306-z","volume":"18","author":"YH Huang","year":"2017","unstructured":"Huang YH et al. (2017) DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A. Genome Biol 18: 176","journal-title":"Genome Biol"},{"key":"5_CR48","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cell.2016.08.056","volume":"167","author":"XS Liu","year":"2016","unstructured":"Liu XS et al. (2016) Editing DNA methylation in the mammalian genome. Cell 167:233\u2013247. e17","journal-title":"Cell"},{"key":"5_CR49","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/nar\/gkaf637","volume":"53","author":"S Amistadi","year":"2025","unstructured":"Amistadi S et al. (2025) Dissecting the epigenetic regulation of the fetal hemoglobin genes to unravel a novel therapeutic approach for \u03b2-hemoglobinopathies. Nucleic Acids Res 53:637","journal-title":"Nucleic Acids Res"},{"key":"5_CR50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40035-022-00314-0","volume":"11","author":"H Park","year":"2022","unstructured":"Park H et al. (2022) CRISPR\/dCas9-Dnmt3a-mediated targeted DNA methylation of APP rescues brain pathology in a mouse model of Alzheimer\u2019s disease. Transl Neurodegener 11:41","journal-title":"Transl Neurodegener"},{"key":"5_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-023-01546-1","volume":"15","author":"JR Tejedor","year":"2023","unstructured":"Tejedor JR et al. (2023) CRISPR\/dCAS9-mediated DNA demethylation screen identifies functional epigenetic determinants of colorectal cancer. Clin Epigenetics 15: 133","journal-title":"Clin Epigenetics"},{"key":"5_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21188-2","volume":"12","author":"J Li","year":"2021","unstructured":"Li J et al. (2021) Programmable human histone phosphorylation and gene activation using a CRISPR\/Cas9-based chromatin kinase. Nat Commun 12: 896","journal-title":"Nat Commun"},{"key":"5_CR53","doi-asserted-by":"publisher","first-page":"113551","DOI":"10.1016\/j.yexcr.2023.113551","volume":"425","author":"H Huang","year":"2023","unstructured":"Huang H et al. (2023) Epigenome editing based on CRISPR\/dCas9p300 facilitates transdifferentiation of human fibroblasts into Leydig-like cells. Exp Cell Res 425:113551","journal-title":"Exp Cell Res"},{"key":"5_CR54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13072-017-0129-1","volume":"10","author":"M Okada","year":"2017","unstructured":"Okada M et al. (2017) Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells. Epigenet Chromat 10:24","journal-title":"Epigenet Chromat"},{"key":"5_CR55","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/978-1-0716-4051-7_7","volume":"2842","author":"S Morita","year":"2024","unstructured":"Morita S, Horii T, Hatada I (2024) Optimized protocol for the regulation of DNA methylation and gene expression using modified dCas9-SunTag platforms. Methods Mol Biol 2842:155\u2013165","journal-title":"Methods Mol Biol"},{"key":"5_CR56","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nprot.2017.016","volume":"12","author":"J Joung","year":"2017","unstructured":"Joung J et al. (2017) Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat Protoc 12:828\u2013863","journal-title":"Nat Protoc"},{"key":"5_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04048-4","volume":"9","author":"PI Thakore","year":"2018","unstructured":"Thakore PI et al. (2018) RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors. Nat Commun 9: 1674","journal-title":"Nat Commun"},{"key":"5_CR58","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.cell.2017.10.025","volume":"171","author":"HK Liao","year":"2017","unstructured":"Liao HK et al. (2017) In vivo target gene activation via CRISPR\/Cas9-mediated trans-epigenetic modulation. Cell. 171:1495\u20131507","journal-title":"Cell."},{"key":"5_CR59","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","volume":"385","author":"JD Gillmore","year":"2021","unstructured":"Gillmore JD et al. (2021) CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. N Engl J Med 385:493\u2013502","journal-title":"N Engl J Med"},{"key":"5_CR60","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ymthe.2025.08.047","volume":"34","author":"L Yuan","year":"2026","unstructured":"Yuan L et al. (2026) Epigenome editing based treatment: progresses and challenges. Mol Ther 34:46\u201367","journal-title":"Mol Ther"},{"key":"5_CR61","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/nmeth.3630","volume":"12","author":"PI Thakore","year":"2016","unstructured":"Thakore PI et al. (2016) Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nat Methods 12:1143\u20131149","journal-title":"Nat Methods"}],"container-title":["Methods in Molecular Biology","CRISPR Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5547-4_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:19:13Z","timestamp":1790068753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5547-4_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"ISBN":["9781071655467","9781071655474"],"references-count":61,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5547-4_5","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"23 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this chapter.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}